When topicals fall short, oral Janus kinase inhibitors offer a needed solution in chronic hand eczema by Christopher G. Bunick, MD, PhD

Get full text

Surface keratin 1, a tumor-selective peptide target in human triple-negative breast cancer by Shih-Jing Yao, Farideh Amirrad, Elmira Ziaei, Azam Saghaeidehkordi, Moom R. Roosan, Kiumars Shamloo, Ajay Sharma, Rachita K. Sumbria, Surya M. Nauli, Christopher G. Bunick, Kamaljit Kaur

Get full text

Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management by Samer Wahood, Omar Alani, Iyla Draw, Lara Shqair, David Wang, Christopher G. Bunick, Giovanni Damiani, Jonathan D. Ho, Sabine Obagi, Hossein Akbarialiabad, Fabrizio Galimberti, Mahmoud Ghannoum, Ayman Grada

Get full text

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry by Jonathan I. Silverberg, Brian M. Calimlim, Ayman Grada, Christopher G. Bunick, Melinda J. Gooderham, Vivian Y. Shi, Chibuzo Obi, Keith D. Knapp, Breda Munoz, Julie M. Crawford, Amy S. Paller

Get full text

Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis by Jonathan I. Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E. Pink, Diego Ruiz Dasilva, Shawn G. Kwatra, Yousef Binamer, Norito Katoh, Valeria Aoki, Alvaro Moreira, Ayman Grada, Chao Li, Brian Calimlim, Wan-Ju Lee, Christopher G. Bunick

Get full text